Kasit Chatsirisupachai

Kasit Chatsirisupachai

Auto-generated profile, based on publicly available information

Kasit Chatsirisupachai

Genome Biology Unit, EMBL Heidelberg, Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2022 in Trends in Cancer
Verified
Journal Article
Open access
KCKasit Chatsirisupachai
Kasit Chatsirisupachai
CLCyril Lagger
Cyril Lagger
JMJoao Pedro Magalhaes
Joao Pedro Magalhaes
Cancer is an age-related disease, as incidence and mortality for most types of cancer increase with age. However, how molecular alterations in tumors differ among patients of different ages remains poorly understood. Recent studies have shed light on the age-associated molecular landscapes in cancer. Here, we summarize the main findings of these current studies, highlighting major differences in the genomic, transcriptomic, epigenetic, and immunological landscapes between cancer in younger and older patients. Importantly, some cancer driver genes are mutated more frequently in younger or older patients. We discuss the potential roles of aging-related processes in shaping these age-related differences in cancer. We further emphasize the remaining unsolved questions that could provide important insights that will have implications in personalized medicine.

31 March 2025 in Molecular Systems Biology
Verified
Journal Article
Open access
KCKasit Chatsirisupachai
Kasit Chatsirisupachai
CMChristina J I Moene
Christina J I Moene
RKRozemarijn Kleinendorst
Rozemarijn Kleinendorst
EKElisa Kreibich
Elisa Kreibich
NMNacho Molina
Nacho Molina
AKArnaud Krebs
Arnaud Krebs
The general transcription machinery and its occupancy at promoters are highly conserved across metazoans. This contrasts with the kinetics of mRNA production that considerably differ between model species such as Drosophila and mouse. The molecular basis for these kinetic differences is currently unknown. Here, we used Single-Molecule Footprinting to measure RNA Polymerase II (Pol II) occupancy, the fraction of DNA molecules bound, at promoters in mouse and Drosophila cell lines. Single-molecule data reveals that Pol II occupancy is on average 3–5 times more frequent at transcriptionally active Drosophila promoters than active mouse promoters. Kinetic modelling of the occupancy states suggests that these differences in Pol II occupancy are determined by the ratio between the transcription initiation and Pol II turnover rates. We used chemical perturbation of transcription initiation to determine Pol II turnover rate in both species. Integration of these data into the model shows that infrequent Pol II occupancy in mouse is explained by the combination of high Pol II turnover and low transcription initiation rates.

31 July 2026 in Nature Genetics
Verified
Journal Article
Open access
PDF file
VBValentina Baderna
Valentina Baderna
GBGuido Barzaghi
Guido Barzaghi
RKRozemarijn Kleinendorst
Rozemarijn Kleinendorst
KCKasit Chatsirisupachai
Kasit Chatsirisupachai
LMLaura Moniot-Perron
Laura Moniot-Perron
AKArnaud R. Krebs
Arnaud R. Krebs
In eukaryotes, transcription factors (TFs) must continuously compete with nucleosomes to access their binding sites, leading to cell-to-cell variability in chromatin accessibility at regulatory regions. Although critical to understand enhancer function in transcription, the mechanisms that define how frequently an enhancer is active in a cell population remain unclear. Here we used single-molecule footprinting to quantify the frequency at which chromatin is accessible at enhancers in response to TF perturbations and changes in their chromatin environment. We find that, individually, most TFs open chromatin in a small fraction of cells, and that cumulative TF binding controls enhancer activation frequency. Moreover, testing the functionality of hundreds of enhancers when inserted at an ectopic genomic location indicates that p300 activity is required for their full activation. Our data support a model in which enhancer activation frequency depends on the cumulative function of multiple TFs and is modulated by p300 activity.

23 August 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
RARoberto A. Avelar
Roberto A. Avelar
JOJavier Gómez Ortega
Javier Gómez Ortega
RTRobi Tacutu
Robi Tacutu
ETEleanor Tyler
Eleanor Tyler
DBDominic Bennett
Dominic Bennett
JMJoao Pedro Magalhaes
Joao Pedro Magalhaes
Cellular senescence, a permanent state of replicative arrest in otherwise proliferating cells, is a hallmark of ageing and has been linked to ageing-related diseases like cancer. Senescent cells have been shown to accumulate in tissues of aged organisms which in turn can lead to chronic inflammation. Many genes have been associated with cell senescence, yet a comprehensive understanding of cell senescence pathways is still lacking. To this end, we created CellAge ( http://genomics.senescence.info/cells ), a manually curated database of 279 human genes associated with cellular senescence, and performed various integrative and functional analyses. We observed that genes promoting cell senescence tend to be overexpressed with age in human tissues and are also significantly overrepresented in anti-longevity and tumour-suppressor gene databases. By contrast, genes inhibiting cell senescence overlapped with pro-longevity genes and oncogenes. Furthermore, an evolutionary analysis revealed a strong conservation of senescence-associated genes in mammals, but not in invertebrates. Using the CellAge genes as seed nodes, we also built protein-protein interaction and co-expression networks. Clusters in the networks were enriched for cell cycle and immunological processes. Network topological parameters also revealed novel potential senescence-associated regulators. We then used siRNAs and observed that of 26 candidates tested, 19 induced markers of senescence. Overall, our work provides a new resource for researchers to study cell senescence and our systems biology analyses provide new insights and novel genes regarding cell senescence.

25 August 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
KCKasit Chatsirisupachai
Kasit Chatsirisupachai
TLTom Lesluyes
Tom Lesluyes
LPLuminita Paraoan
Luminita Paraoan
PLPeter Van Loo
Peter Van Loo
JMJoao Pedro Magalhaes
Joao Pedro Magalhaes
Age is the most important risk factor for cancer, as cancer incidence and mortality increase with age. However, how molecular alterations in tumours differ among patients of different age remains largely unexplored. Here, using data from The Cancer Genome Atlas, we comprehensively characterised genomic, transcriptomic and epigenetic alterations in relation to patients’ age across cancer types. We showed that tumours from older patients present an overall increase in genomic instability, somatic copy-number alterations (SCNAs) and somatic mutations. Age-associated SCNAs and mutations were identified in several cancer-driver genes across different cancer types. The largest age-related genomic differences were found in gliomas and endometrial cancer. We identified age-related global transcriptomic changes and demonstrated that these genes are controlled by age-associated DNA methylation changes. This study provides a comprehensive view of age-associated alterations in cancer and underscores age as an important factor to consider in cancer research and clinical practice.

24 September 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
KCKasit Chatsirisupachai
Kasit Chatsirisupachai
CMChristina J.I. Moene
Christina J.I. Moene
RKRozemarijn Kleinendorst
Rozemarijn Kleinendorst
EKElisa Kreibich
Elisa Kreibich
NMNacho Molina
Nacho Molina
AKArnaud Krebs
Arnaud Krebs
The general transcription machinery and its occupancy at promoters are highly conserved across metazoans. This contrasts with the kinetics of mRNA production that considerably differ between model species such as Drosophila and mouse. The molecular basis for these kinetic differences is currently unknown. Here, we used Single Molecule Footprinting to measure RNA Polymerase II (Pol II) occupancy, the fraction of DNA molecules bound, at promoters in mouse and Drosophila cell lines. Single molecule data reveals that Pol II occupancy is on average 3-5 times more frequent at transcriptionally active Drosophila promoters than active mouse promoters. Kinetic modelling of the occupancy states suggests that these differences in Pol II occupancy are determined by the ratio between the transcription initiation and Pol II turnover rates. We used chemical perturbation of transcription initiation to determine Pol II turnover rate in both species. Integration of these data into the model shows that infrequent Pol II occupancy in mammals is explained by the combination of high Pol II turnover and low transcription initiation rates.